| Answers |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Real Estate > Real Estate > 2006 Third-Quarter Housing Numbers Not Headlines Portray Reality |
|
Answers - 2006 Third-Quarter Housing Numbers Not Headlines Portray Reality
Bubble this, dramatic decline that, and housing bust to boot. If you relied on headlines in 2006 to make resi According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product dential real estate decisions, you were misled. The statistics tell the real story, yes, not a pretty one in ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in ll markets. Stripping away the hype will give you an accurate picture of what did and didn’t happen. The Nati lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. nal Association of Realtors released their numbers for the third quarter of 2006. Like it or not, the associa here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe ion’s numbers are viewed by national economists and the federal government as reliable. Homes resold in the d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro hird quarter on average nationally had sales prices slightly over one-percent less than the same period in 20 ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc 5. That is a change from recent years and is historically, unusual. However, after five years of double-digit easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi rises in median home sale prices, the market in 2007 will define what it does or doesn’t mean, long-term. Wha nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically many headlines failed to report was the substantial decline in the number of sold properties. Markets that and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ xperienced increases in median prices: -Beaumont, Texas -Chicago, Illinois -New York, New York -Philadelp ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi ia, Pennsylvania -Portland, Oregon -Salt Lake City, Utah -San Francisco, California -Seattle, Washington ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a -Vancouver, Washington And the decliners in the third-quarter 2006 average sales-price numbers: -Boston, Ma dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod sachusetts -Detroit, Michigan -Ft. Lauderdale, Florida -Miami, Florida -Providence, Rhode Island -Distri cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin t of Columbia -San Diego, California -Sarasota, Florida States experiencing major declines in closed sales tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen volume: -Arizona -California -Florida -Nevada -Washington, D.C. What the numbers don’t tell you is that t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel the country is comprised of thousands of real estate markets. Each local market has unique characteristics th ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust t include supply and demand, buyer and seller market perceptions, unique mortgage programs, and regional econ y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products mies. Generalizations about the residential real estate market should be avoided, because every day opposing . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de tatistics are released. Rely only on market times, available inventory and closed sales prices in the local M elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip ltiple Listing Services or public records from the last six months to make your real estate decisions in 2007 tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Use Of Ezines To Drive Massive Traffic To Your Websites Selecting The Right Credit Card
|